Evidence map›Paper›PMID 25311266›Full record

ReviewAdvances in biological regulation2015

Exploring phosphatidylinositol 5-phosphate 4-kinase function.

Simon J Bulley, Jonathan H Clarke, Alaa Droubi, Maria-Luisa Giudici, Robin F Irvine

Abstract readReview
In one paragraph

Review in Advances in biological regulation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Development of potent and selective degraders of PI5P4Kγ.European journal of medicinal chemistry · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Discovery and Structure-Activity Relationship Study of (Journal of medicinal chemistry · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Simon J BulleyDepartment of Pharmacology, Tennis Court Road, Cambridge, CB2 1PD, UK.
Jonathan H ClarkeDepartment of Pharmacology, Tennis Court Road, Cambridge, CB2 1PD, UK.
Alaa DroubiDepartment of Pharmacology, Tennis Court Road, Cambridge, CB2 1PD, UK.
Maria-Luisa GiudiciDepartment of Pharmacology, Tennis Court Road, Cambridge, CB2 1PD, UK.
Robin F IrvineDepartment of Pharmacology, Tennis Court Road, Cambridge, CB2 1PD, UK. Electronic address: rfi20@cam.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council RG65394Medical Research Council MR/J001120/1Medical Research Council RG64071
6 · The paper itself

Abstract

The family of phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) is emerging from a comparative backwater in inositide signalling into the mainstream, as is their substrate, phosphatidylinositol 5-phosphate (PI5P). Here we review some of the key questions about the PI5P4Ks, their localisation, interaction, and regulation and also we summarise our current understanding of how PI5P is synthesised and what its cellular functions might be. Finally, some of the evidence for the involvement of PI5P4Ks in pathology is discussed.

Indexed as

AnimalsHumansPhosphatidylinositol PhosphatesPhosphotransferases (Alcohol Group Acceptor)Signal Transduction1-phosphatidylinositol-4-phosphate 5-kinasephosphatidylinositol 5-phosphatePhosphatidylinositol PhosphatesPhosphotransferases (Alcohol Group Acceptor)InositideKinasePhosphatidylinositolPhosphatidylinositol 5-phosphatePhosphatidylinositol 5-Phosphate4-kinase

Identifiers

PMID25311266
PMCPMC4359101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.